BioProcess International is part of the Informa Connect Division of Informa PLC
Informa PLC
|
ABOUT US
|
INVESTOR RELATIONS
|
TALENT
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
keyboard_arrow_up
BPI Events
About
Subscribe
Contribute
menu
Menu
search
Search
search
Search
menu
Subscribe
Subscribe
search
close
menu
Upstream
keyboard_arrow_down
Related Topics
Bioreactors
Biochemicals/Raw Materials
Cell Culture Media
Expression Platforms
Microbial Cell Culture
Perfusion Cell Culture
Recent in
Upstream
See all
chevron_right
Sponsored Content
Buffer Outsourcing: Enabling Flexible Biopharmaceutical Manufacturing Through High-Concentration Buffer Technologies
Buffer Outsourcing: Enabling Flexible Biopharmaceutical Manufacturing Through High-Concentration Buffer Technologies
by
Gearoid O’Rourke
Aug 25, 2026
Perfusion Cell Culture
Continuous Biomanufacturing and Perfusion Technologies Are Finally on the Cusp of Broad Adoption
Continuous Biomanufacturing and Perfusion Technologies Are Finally on the Cusp of Broad Adoption
by
Smita Khanna
Aug 19, 2026
Downstream
keyboard_arrow_down
Related Topics
Chromatography
Filtration
Separation/Purification
Viral Clearance
Recent in
Downstream
See all
chevron_right
Sponsored Content
Advancing High-Concentration mAb Processing Through Improved TFF Cassette Design
Advancing High-Concentration mAb Processing Through Improved TFF Cassette Design
by
Anika Manzke,
Katy McLaughlin
Aug 21, 2026
Separation/Purification
docs
Enhancing purity of an Emtansine biosimilar ADC through mixed mode
Enhancing purity of an Emtansine biosimilar ADC through mixed mode
Jul 17, 2026
Manufacturing
keyboard_arrow_down
Related Topics
Biosimilars
Continuous Bioprocessing
Facility Design/Engineering
Formulation
Single Use
Fill/Finish
Information Technology
Process Monitoring and Controls
Supply Chain
Validation
CMC Forums
Recent in
Manufacturing
See all
chevron_right
Information Technology
How We Can Collectively Accelerate Digital Transformation in Biomanufacturing: Scalable Adoption Frameworks Discussed During Roundtable 5 of the 2025 BioInnovation Group Executive Summit
How We Can Collectively Accelerate Digital Transformation in Biomanufacturing: Scalable Adoption Frameworks Discussed During Roundtable 5 of the 2025 BioInnovation Group Executive Summit
by
Maurice Phelan,
Barry Heavey
Sep 1, 2026
Sponsored Content
eBook: Technology Transfer — Minding the Gaps Amid Digital Transformation
eBook: Technology Transfer — Minding the Gaps Amid Digital Transformation
by
Dan Stanton,
Josh Abbott
and 2 more
Aug 31, 2026
Analytical
keyboard_arrow_down
Related Topics
QA/QC
Cell Line Development
PAT
Product Characterization
Bioanalytical Methods
Process Development
Assays
Laboratory Equipment
Recent in
Analytical
See all
chevron_right
Sponsored Content
eBook: Technology Transfer — Minding the Gaps Amid Digital Transformation
eBook: Technology Transfer — Minding the Gaps Amid Digital Transformation
by
Dan Stanton,
Josh Abbott
and 2 more
Aug 31, 2026
Cell Line Development
tv_signin
Current Perspectives: Cell Line Engineering and Expression Optimization
Current Perspectives: Cell Line Engineering and Expression Optimization
Aug 26, 2026
55 Min View
Business
keyboard_arrow_down
Related Topics
Bioregions
Careers & Training
Contract Services
Economics
Pre-Clinical & Clinical Trials
Risk Management
Intellectual Property
Regulatory Affairs
Recent in
Business
See all
chevron_right
Information Technology
How We Can Collectively Accelerate Digital Transformation in Biomanufacturing: Scalable Adoption Frameworks Discussed During Roundtable 5 of the 2025 BioInnovation Group Executive Summit
How We Can Collectively Accelerate Digital Transformation in Biomanufacturing: Scalable Adoption Frameworks Discussed During Roundtable 5 of the 2025 BioInnovation Group Executive Summit
by
Maurice Phelan,
Barry Heavey
Sep 1, 2026
Business
Lilly to acquire biotech firm Merida in $2.87bn deal
Lilly to acquire biotech firm Merida in $2.87bn deal
by
Josh Abbott
Aug 31, 2026
2 Min Read
Therapeutic Modalities
keyboard_arrow_down
Related Topics
Cell Therapies
Emerging Therapeutics
Gene Therapies
Large Molecule Development
MAb
Personalized Medicine
Vaccines
Recent in
Therapeutic Modalities
See all
chevron_right
Cell Therapies
Why Retinal Diseases Could Become the Proving Ground for the Next Generation of Regenerative Therapies
Why Retinal Diseases Could Become the Proving Ground for the Next Generation of Regenerative Therapies
by
Jogin Desai
Aug 31, 2026
Cell Therapies
Decentralized Apheresis: The Missing Link in Equitable Cell and Gene Therapy Access?
Decentralized Apheresis: The Missing Link in Equitable Cell and Gene Therapy Access?
by
Adrienne Mendoza,
Becky Cap
and 1 more
Aug 18, 2026
BioProcess Insider
keyboard_arrow_down
Related Topics
Deal-Making
Facilities & Capacity
Global Markets
Regulations
Therapeutic Class
Upstream & Downstream Processing
Webcasts
BioProcess Insider Podcasts
Recent in
BioProcess Insider
See all
chevron_right
Business
Lilly to acquire biotech firm Merida in $2.87bn deal
Lilly to acquire biotech firm Merida in $2.87bn deal
by
Josh Abbott
Aug 31, 2026
2 Min Read
Biosimilars
Argentine firm Biosidus completes $12.9m biomanufacturing expansion
Argentine firm Biosidus completes $12.9m biomanufacturing expansion
by
Josh Abbott
Aug 28, 2026
2 Min Read
search
close
404 Error
Going the wrong way?
Sorry, the page you requested cannot be found.
Back to home page